When to increase dose Increase if : Minimal results after 4-6 weeks at standard dose Tolerating well with no side effects Weight/size justifies higher dose Researched safe dose range How to increase : 25-50% increase, not doubling Monitor for side effects Give 2-4 weeks at new dose before further changes Example : BPC-157 250mcg 2x daily not working well after 6 weeks increase to 500mcg 2x daily When to reduce dose Reduce if : Side effects at current dose Achieved results, transitioning to maintenance Cost concerns Tolerance issues How to reduce : Decrease 25-50% Monitor if results maintained Can taper over 2-4 weeks When to stop early Stop if : Severe side effects Goal achieved earlier than expected Financial emergency Health issues arise Pregnancy How to stop : GLP-1 peptides should taper Assess results vs original goals Frequently asked questions Q: How long should I run BPC-157
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide of 15 amino acids
MPLfcinB6 created by linking 7 arginines to LfcinB via glycine-glycine binding sites, effectively eliminates human T-leukaemia cells with an IC50 value of 25 M, which is half of what it was before modification (35,36)
Frank M
Conclusion GHK-Cu represents a fascinating area of research for its multifaceted effects on skin health, particularly its potential in wound healing, inflammation reduction, and scar remodeling
Both peptides have relatively short half-lives, meaning consistent daily administration is necessary to sustain their respective metabolic effects throughout a research protocol.
